Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Sodium cromoglicate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Opticrom Allergy Single Dose 2% w/v Eye Drops, solution (called Opticrom Allergy Single Dose in this leaflet) contains a medicine called sodium cromoglicate. This belongs to a group of medicines called anti allergics. What Opticrom Allergy Single Dose is used for Opticrom Allergy Single Dose is used to relieve and treat eye allergies in adults and children. There are two types of eye allergy:
Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. Driving and using machines You may have blurred eye-sight just after using this medicine. If this happens, do not drive or use any tools or machines until you can see clearly.
Opticrom Allergy Single Dose Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. How much to use The recommended dose is:
65NOT6547/D
If you stop using Opticrom Allergy Single Dose
Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop using Opticrom Allergy Single Dose and talk to a doctor straight away if: It is not known how often these happen.
Opticrom Allergy Single Dose Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month. Store below 25°C. Keep the single-dose containers in the aluminium sachet in order to protect from light. After opening the aluminium sachet, throw away any remaining contents after 28 days. Once opened, use the single-dose container immediately. After use, throw away the container and any medicine left in it – do not use again. This is because the Opticrom Allergy Single Dose container is sterile and preservative-free. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
65NOT6547/D
What Opticrom Allergy Single Dose contains
Opticrom Allergy Single Dose 2% w/v Eye Drops, Solution comes as eye drops. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Opticrom Allergy Single Dose 2% w/v Eye Drops, Solution is sodium cromoglicate.
Medicines with the same active substance, strength and form include: Allercrom 2% w/v Eye Drops, Allergy Relief 2% w/v eye drops, Solution, Aspire Hayfever Relief 2% w/v Eye Drops, solution. In total there are 18 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Opticrom Allergy Single Dose 2% w/v Eye Drops, Solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
For the relief and treatment of seasonal and perennial allergic conjunctivitis.
Posology
Adults and children
The recommended dose is one or two drops in each eye four times a day.
Opticrom Single Dose should be used regularly to ensure optimal control of symptoms. It is recommended that treatment is continued during the period of exposure to allergen.
Special population
Older people
No current evidence for alteration of the dose.
Paediatric
In children, caregiver supervision and/or assistance may be required
Method of administration
For ocular use only.
It should be administered in the conjunctival sac of the affected eye.
To avoid contamination, the tip of the container should not touch the eye or any surface (see section 4.4).
As with most ophthalmic preparations, contact lenses should be removed before each application and may be inserted after 15 minutes.
In case of concomitant treatment with other eye drops, instillations should be 15 minutes apart.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Opticrom Single Dose is sterile, preservative-free, and presented in a single-dose container which should be used immediately after opening and any remaining contents discarded after use.
Patients wearing contact lenses: see section 4.2.
No interactions studies have been performed.
Pregnancy
As with all medication, caution should be exercised especially during the first trimester of pregnancy. Cumulative experience with sodium cromoglicate suggests that it has no adverse effects on foetal development. It should be used in pregnancy only where there is a clear need.
Breast-feeding
It is not known whether sodium cromoglicate is excreted in human breast milk but, on the basis of its physicochemical properties, this is considered unlikely. There is no information to suggest the use of sodium cromoglicate has any undesirable effects on the baby.
Fertility
Animal studies did not show any effect on fertility. It is not known if sodium cromoglicate has an effect on human fertility.
As with all eye drops, instillation of these eye drops may cause a transient blurring of vision. Patients are advised not to drive or operate machinery if affected, until their normal vision has been re-established.
Frequencies are based on the MedDRA frequency convention and defined as: very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000); not known (cannot be estimated from the available data).
Eye Disorders
Not known: transient stinging and burning may occur after instillation. Other symptoms of local irritation have been reported.
Immune System Disorders
Not known: hypersensitivity reactions have been reported
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
No action other than medical observation should be necessary.
Ask anything about Opticrom Allergy Single Dose 2% w/v Eye Drops, Solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.